SEC Form 4 · accession 0001387131-16-008704
TherapeuticsMD, Inc. · TXMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cooper C. Collins
Director
Period of report
Dec 21, 2016
Accepted (ET)
Dec 22, 2016 · 7:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000025743
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $5.68 | Dec 21, 2016 | A | 25,000 | A | Dec 21, 2017 | Dec 20, 2026 | Common Stock | 25,000 | 25,000 | D |